Abiopharma

Celcuity Inc Notification (CELC)

Teladoc - Teladoc Health to Participate in Upcoming Investor Conference

Nuvation Bio Inc. - Nuvation Bio to Participate in Upcoming Investor Conferences

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium

Teladoc Health to Participate in Upcoming Investor Conference

Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors

DEFA14A (Additional Proxy Soliciting Materials (definitive)) SEC Filing